Our findings suggest that Notch1 signaling is a key regulator in ECs of the BBB in the setting of mitochondrial dysfunction and strengthen the effect of Notch1 signaling as a therapeutic target for maintaining BBB integrity in cerebrovascular disease. Here, NOTCH1 is linked to cerebrovascular disorder.